Clinical Updates

Data that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines… »   

Shortly before Japan’s devastating nuclear incident, researchers at Thomas Jefferson University and Hospitals received an award to find novel drugs… »   

Pfizer Inc reported disappointing quarterly revenue on declining demand for its prescription medicines, exposing the risks the world’s biggest drugmaker… »   

While well known for relieving everyday aches and pains, few realize that when misused, acetaminophen can lead to acute liver… »   

University of Cincinnati (UC) researchers have determined why a certain class of diabetes drugs leads to weight gain and have… »   

A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study… »   

A Virginia U.S. District Court jury has ordered Allergan Inc to pay $212 million to a man who claimed that… »   

A Virginia District Court jury has ordered Allergan Inc to pay $212 million to a man who claimed that injections… »   

A large trial comparing treatments for typhoid has backed the use of gatifloxacin, an antibiotic launched by Bristol Myers Squibb… »   

Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat… »   

They were able to show for the first time that physiologically measurable changes can be observed in the brains of… »   

Tumor progression is usually ensured by more than one proliferative mechanism. When one of these is shut down by a… »   

U.S. drugmaker Merck and German diagnostics firm Qiagen are donating millions of human papillomaviros (HPV) vaccines and 250,000 HPV tests… »   

Unintentional overdose deaths in teens and adults have reached epidemic proportions in the U.S. In some 20 states in 2007… »   

The brain infection risk from Biogen Idec’s multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S.… »